entity

protein

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about protein: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections

30Hypotheses

30Analyses

10Outgoing

3Incoming

8Experiments

20Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (10)

Target	Relation	Type	Str
protein folding	involved_in	process	0.95
secondary structure	involved_in	process	0.95
amino acid sequence	involved_in	process	0.90
Alzheimer'S Disease	biomarker_for	disease	0.88
Distant Pqtl Effects	mediates	mechanism	0.88
NEURODEGENERATION	associated_with	disease	0.80
PROTEOSTATIC INTEGRITY	regulates	process	0.80
NETWORK-LEVEL COMPUTATION	regulates	process	0.80
ORGANELLE COMMUNICATION	regulates	process	0.80
protein_quantitative_trait_loci	mediates	phenotype	0.80

Incoming (3)

Source	Relation	Type	Str
biomarkers-gap-43-growth-associated-protein	describes	wiki	0.90
LncRNA	interacts_with	biomarker	0.80
NEMO	interacts_with	protein	0.70

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
eIF2α Phosphorylation Imbalance Creates Integrated Stress Re	0.866	ALS	-
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
C9orf72 Hexanucleotide Repeat Dipeptide Repeat Proteins Inhi	0.738	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Bl	0.735	-	What blood-brain barrier permeability ch
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides	0.718	neurodegeneration	Blood-brain barrier transport mechanisms

Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Pr	0.675	-	What blood-brain barrier permeability ch
J-protein co-chaperone repertoire enables selective recognit	0.642	protein biochemistry	Do chaperones selectively recognize path
Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Bl	0.640	-	What blood-brain barrier permeability ch
Pericyte senescence is sufficient to weaken the BBB even wit	0.630	neurodegeneration	Does pericyte senescence drive BBB break
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
RNA-Binding Protein Sequestration and 3′UTR Dysregulation	0.625	-	How does the intron-retained RNA isoform
Heat Shock Protein 70 Disaggregase Amplification	0.625	neurodegeneration	TDP-43 phase separation therapeutics for
Serine/Arginine-Rich Protein Kinase Modulation	0.624	neurodegeneration	TDP-43 phase separation therapeutics for
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m	0.621	neurodegeneration	Mitochondrial transfer between astrocyte
Tau fibrils expose neuronal phosphatidylserine and heat-shoc	0.620	neurodegeneration	Synaptic pruning by microglia in neurode
CSF ApoE- and clusterin-rich lipoprotein particles stabilize	0.606	neurodegeneration	Which specific CSF molecular components
TREM2-mediated PV interneuron stabilization to restore gamma	0.583	neurodegeneration	-
A genetically encoded reporter for axonal mitochondrial prot	0.565	neuroscience	How can subcellular compartmentalization
TREM2-complement-amyloid axis as therapeutic target for prot	0.550	unknown	-
VPS35 Retromer Restoration to Rescue Endosomal Protein Traff	0.525	proteomics	Quantitative proteomics of the aging syn
Matrix Metalloproteinase-9-Mediated Claudin-5 Cleavage Drive	0.515	-	What blood-brain barrier permeability ch
Circulating IBA1 Protein Absorption/Interference with Detect	0.507	neuroinflammation	What causes IBA1 low/negative microglia
RNA-binding proteins stabilize or gate the lncRNA-0021:mmu-m	0.497	molecular neurobiology	How does lncRNA-0021 achieve sequence-sp
Conditional CRISPR Kill Switches for Aberrant Protein Cleara	0.496	neurodegeneration	CRISPR-based therapeutic approaches for
Sulfated glycans and metal-binding CSF proteins brace alpha-	0.489	neurodegeneration	Which specific CSF molecular components
Distinct J-protein architectures decode exposed β-sheet reco	0.484	protein biochemistry	Do chaperones selectively recognize path
CHIP E3 Ligase Enhancement to Target Synaptic Proteins for D	0.474	proteomics	Quantitative proteomics of the aging syn
Synaptic Vesicle Protein Phosphorylation Reprograms Release	0.455	neurodegeneration	Quantitative proteomics of the aging syn
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote	0.000	ALS	-

Mentioning Analyses (30)

Scientific analyses that reference this entity

Proteogenomic Network Hubs as Druggable Targets in Early PD Neurodegeneration

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.626

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.662

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosida

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.645

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.847

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.712

Experiments (8)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Indiv	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$6,550,000
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau	clinical	Alzheimer's Disease	0.400	0.50	cell_line	proposed	$180,000
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investig	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,100,000
ApoE4 Function in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	mouse	proposed	$360,000
Blood-Based Biomarker Panel for Early AD Detection	clinical	Alzheimer's Disease	0.400	0.50	cell_line	proposed	$220,000
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeutic Timing	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,730,000
Sex Differences in Alzheimer's Disease — mechanisms and therapeutic im	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044]	Calvier L, Herz J, Hansmann G	JACC Basic Transl Sci	2022	1
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. [PMID:36348357]	Raulin AC, Doss SV, Trottier ZA, Ikezu T	Mol Neurodegener	2022	1
Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216]	Banik SM, Pedram K, Wisnovsky S, Ahn G,	Nature	2020	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventin [PMID:30595089]	Brophy ML, Dong Y, Tao H, Yancey PG, Son	Circ Res	2019	1
Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical [PMID:28381441]	Shinohara M, Tachibana M, Kanekiyo T, Bu	J Lipid Res	2017	1
APOE-Targeted Therapeutics for Alzheimer's Disease. [PMID:41224653]	["Yassine H", "Hugo C", "O'Donovan B", "	The Journal of neuroscience :	2025	0
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker [PMID:39841474]	["Oomens J", "van Gils V", "Vos S", "Fre	JAMA network open	2025	0
AMBP protects against aortic valve calcification by inhibiting ERK1/2 and JNK pa [PMID:40225558]	["Guo C", "Liu X", "Mei Z", "Chang M", "	Theranostics	2025	0
Blood-based pre-screening in the SKYLINE secondary prevention Ph3 gantenerumab s [PMID:41085131]	["Bauer A", "Rabe C", "Schiffman C", "Ro	Alzheimer's & dementia : the j	2025	0
ApoE-Corona oncolytic adenovirus nanoparticles enable blood-brain barrier penetr [PMID:40987376]	Ge T, Niu A, Lv Y, Chen Y, Liu Y, Lei X,	Journal of controlled release	2025	0
Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alv [PMID:38671323]	["Theobald H", "Bejarano D", "Katzmarski	Nature immunology	2024	0
C/EBPβ: A transcription factor associated with the irreversible progression of A [PMID:38644578]	["Yao Q", "Long C", "Yi P", "Zhang G", "	CNS neuroscience & therapeutic	2024	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0
Cholesterol Metabolism in Pancreatic Cancer. [PMID:37958351]	["Rebelo A", "Kleeff J", "Sunami Y"]	Cancers	2023	0
Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Target [PMID:36614219]	["Pires M", "Rego A"]	International journal of molec	2023	0
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. [PMID:35750033]	["Tcw J", "Qian L", "Pipalia N", "Chao M	Cell	2022	0
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044]	Calvier L, Herz J, Hansmann G	JACC Basic Transl Sci	2022	0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938]	Li S, Sun Y, Song M, Song Y, Fang Y, Zha	JCI insight	2021	0

Debates (20)

Multi-agent debates referencing this entity

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

active · Rounds: 4 · Score: 0.67 · 2026-04-28

Which proteogenomic network hubs identified by multi-omics PD studies are drugga

active · Rounds: 4 · Score: 0.67 · 2026-04-28

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Related Research

Hypotheses and analyses mentioning protein in their description or question text

Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Preclinical Tight Junc

Score: 0.675 · unknown disease · 2026-04-26

Matrix metalloproteinase-9 (MMP-9) degrades tight junction proteins (claudin-5, occludin, ZO-1) and extracellular matrix

J-protein co-chaperone repertoire enables selective recognition of pathogenic co

Score: 0.642 · protein biochemistry · 2026-04-21

**Molecular Mechanism and Rationale** The J-protein co-chaperone system represents a sophisticated cellular quality con

Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indi

Score: 0.640 · unknown disease · 2026-04-26

Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction pro

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

Score: 0.630 · neurodegeneration · 2026-04-25

Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-Binding Protein Sequestration and 3′UTR Dysregulation

Score: 0.625 · unknown disease · 2026-04-26

Intron-retained GBA isoform sequesters neuronal RBPs (FMRP, HuR, TDP-43) that normally bind to wild-type GBA mRNA 3′UTR

Heat Shock Protein 70 Disaggregase Amplification

Score: 0.625 · neurodegeneration · 2026-04-02

## Molecular Mechanism and Rationale The HSP70 chaperone system operates as a protein disaggregation machine through an

Serine/Arginine-Rich Protein Kinase Modulation

Score: 0.624 · neurodegeneration · 2026-04-02

## Mechanistic Overview Serine/Arginine-Rich Protein Kinase Modulation starts from the claim that modulating SRPK1 withi

Designer TRAK1-KIF5 fusion proteins accelerate therapeutic mitochondrial deliver

Score: 0.621 · neurodegeneration · 2026-04-02

## Mechanistic Overview Designer TRAK1-KIF5 fusion proteins accelerate therapeutic mitochondrial delivery starts from th

Tau fibrils expose neuronal phosphatidylserine and heat-shock protein 70, drivin

Score: 0.620 · neurodegeneration · 2026-04-22

## Mechanistic Overview Tau fibrils expose neuronal phosphatidylserine and heat-shock protein 70, driving microglial non

CSF ApoE- and clusterin-rich lipoprotein particles stabilize disease-relevant al

Score: 0.606 · neurodegeneration · 2026-04-25

Specific lipoprotein particles bind fibril surfaces and preserve polymorph architecture and seeding fidelity outside the

A genetically encoded reporter for axonal mitochondrial protein import fidelity

Score: 0.565 · neuroscience · 2026-04-26

MTS-dGFP fusion construct requires intact TOM40/TOM20 translocase for mitochondrial import, serving as direct read-out o

protein

Understanding Entity Pages

Wiki Pages (21)

Amyloid Precursor Protein (APP)

APOC4 — Apolipoprotein C-IV

amyloid-beta-metalloproteinases

nf1-protein

nlrc5-protein

APOE — Apolipoprotein E

LRP1B — Low Density Lipoprotein Receptor-Related Protein 1B

IL1RAP — Interleukin-1 receptor accessory protein

atxn3-protein

Update TDP-43 protein page with comprehensive content

epas1-protein

tdp-43-fus-rna-proteinopathy-comparison

snca-protein

HNRNPG — Heterogeneous Nuclear Ribonucleoprotein G

fcgr2a-protein

proteinopathies-skin-neurodegenerative-disorders-nct06528964

CLU — Clusterin (Apolipoprotein J)

gnas-protein

heme-oxygenase-1-protein

rab3b-protein

dlgh2-protein

Outgoing (10)

Incoming (3)

Targeting Hypotheses (30)

Mentioning Analyses (30)

Proteogenomic Network Hubs as Druggable Targets in Early PD Neurodegeneration

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosida

What are the mechanisms by which microglial senescence contributes to ALS pathol

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

Which specific factors in conditioned medium from healthy astrocytes rescue moto

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retenti

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

Proteomics Differential Expression in AD CSF and Brain Tissue

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

Multi-modal Biomarker Panel Design for Early AD Detection

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

What are the specific PTM changes in synaptic vesicle proteins during early AD p

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

How does engineered C. butyricum cross the blood-brain barrier to directly bind

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

What molecular mechanisms explain how KCNJ2 inhibition mitigates TBI-induced neu

How does PIKFYVE inhibition activate unconventional protein clearance via exocyt

What mechanisms explain how IDH1/IDH2 mutations with reduced enzymatic activity

RNA binding protein dysregulation across ALS FTD AD

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

Extracellular vesicle biomarkers for early AD detection

What physicochemical properties determine selective protein recruitment vs exclu

What determines the selectivity and efficiency of intercellular transmission pat

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

Experiments (8)

Related Papers (20)

Debates (20)

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

Which proteogenomic network hubs identified by multi-omics PD studies are drugga

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

Related Research

Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Preclinical Tight Junc

J-protein co-chaperone repertoire enables selective recognition of pathogenic co

Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indi

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

RNA-binding protein condensate maturation from reversible phase separation to am

RNA-binding protein condensate maturation from reversible phase separation to am

RNA-Binding Protein Sequestration and 3′UTR Dysregulation

Heat Shock Protein 70 Disaggregase Amplification